Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EMR
EMR logo

EMR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Emerson Electric Co (EMR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
150.660
1 Day change
1.11%
52 Week Range
165.150
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Emerson Electric Co (EMR) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows strong technical indicators, positive sentiment from Congress trading data, and a stable outlook from analysts. While there are some risks such as project delays and trade conflicts, the company's exposure to secular tailwinds and margin improvements make it a solid long-term investment opportunity.

Technical Analysis

The technical indicators for EMR are bullish. The MACD histogram is positive and expanding, indicating upward momentum. The RSI is at 75.886, which is neutral but leaning towards overbought territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its resistance level of 150.617, with further resistance at 154.501. Support levels are at 144.329 and 138.041.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • Congress trading data shows a positive sentiment with 2 purchase transactions and only 1 sale transaction in the last 90 days.

  • Analysts highlight exposure to secular tailwinds such as power generation and LNG investments.

  • Margin improvements and proactive cost management have been noted by analysts, supporting higher valuation multiples.

Neutral/Negative Catalysts

  • Potential project delays and trade conflicts could impact performance.

  • Exposure to the Middle East (7%) presents near-term risks.

  • Some analysts have expressed concerns about the stock's ability to break out of its trading range.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed but lean positive. RBC Capital raised its price target to $169 with an Outperform rating, while Jefferies upgraded the stock to Buy with a $175 price target. However, some analysts, like DA Davidson and Barclays, maintain Neutral or Equal Weight ratings, citing risks such as trade conflicts and project delays.

Wall Street analysts forecast EMR stock price to rise
14 Analyst Rating
Wall Street analysts forecast EMR stock price to rise
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 149.000
sliders
Low
125
Averages
150.46
High
170
Current: 149.000
sliders
Low
125
Averages
150.46
High
170
DA Davidson
Chris Dankert
Neutral
initiated
$145
AI Analysis
2026-06-15
Reason
DA Davidson
Chris Dankert
Price Target
$145
AI Analysis
2026-06-15
initiated
Neutral
Reason
DA Davidson analyst Chris Dankert initiated coverage of Emerson with a Neutral rating and $145 price target. The company has \"significant exposure to secular tailwinds,\" including increasing power generation demands and liquified natural gas investment, the analyst tells investors in a research note. However, DA says the shares have struggled to break out of their multiple trading range and large project delays along with trade conflicts \"present some offsets.\"
RBC Capital
Outperform
maintain
$161 -> $169
2026-05-06
Reason
RBC Capital
Price Target
$161 -> $169
2026-05-06
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Emerson to $169 from $161 and keeps an Outperform rating on the shares after its Q2 results. Proactive cost management allowed management to raise the low-end of FY26 EPS guidance while assuming 1 percentage point of continued Middle East disruption, lowering organic sales guidance from 4% to 3%, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EMR
Unlock Now

People Also Watch